Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)
Ari Ahn,
Sung-Soo Park,
Yonggoo Kim,
Jung Yeon Lee,
Jong-Mi Lee,
Jin Jung,
Myungshin Kim,
Chang-Ki Min
Affiliations
Ari Ahn
Department of Laboratory Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Sung-Soo Park
Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Haematology, Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul
Yonggoo Kim
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Jung Yeon Lee
Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Haematology, Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul
Jong-Mi Lee
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Jin Jung
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Myungshin Kim
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Chang-Ki Min
Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Haematology, Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul
